How Generic Drugs Save the US Healthcare System Billions
Explore how generic and biosimilar drugs saved the US healthcare system $482 billion in 2024 and why they are critical for reducing pharmaceutical costs.
View moreTag: biosimilars
23
Apr
7
Nov
Insurance Coverage of Biosimilars: Prior Authorization and Tier Placement Strategies
Biosimilars offer major cost savings over biologic drugs, but insurance coverage through prior authorization and tier placement often blocks access. Learn how formulary rules, PBMs, and Medicare policies impact patient affordability and adoption in 2025.
View more
